NCT04726397View on ClinicalTrials.gov

UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial

NACompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

March 29, 2021

Primary Completion Date

May 15, 2024

Study Completion Date

May 15, 2024

Conditions
Glioblastoma Multiforme
Interventions
RADIATION

Reduced margin adaptive radiotherapy

Reduced (5 mm) clinical target volume margin with weekly contrast-enhanced adaptive radiation on the MR-Linac treatment machine

Trial Locations (1)

M4N3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER

NCT04726397 - UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial | Biotech Hunter | Biotech Hunter